The purpose of this study is to evaluating effectiveness and safety of plant origin probiotics on body fat of subjects who are obese aged more than 20 years and less than 65 years old. The study was designed as 12 weeks consumption, randomized, double-blind, parallel, and placebo-control led design.

Others

Subject who voluntarily agree to participate and signs informed consent form at visit1(0week) are diagnosed whether they are suitable or not by inclusive and exclusive criteria. Then subjects are randomly assigned to placebo or plant origin probiotics group according to registered order. Control group takes 2 placebo capsules and test group takes 2 plant origin probiotics capsules (500mg/capsule) once for two times a day for 12 weeks and carrying out the efficacy test at each visit.

Arm Label

Target Number of Participant

Arm Type

Arm Description

Consumption of 2 capsules of plant origin probiotics twice a day for 12 weeks

Arm Label

Target Number of Participant

Arm Type

Arm Description

Consumption of 2 placebo capsules twice a day for 12 weeks

Gender

Age

Description

1) Subject who voluntarily agree to participate and signs informed consent form
2) Aged more than 19 years and less less than 65 years, women and men
3) Those who have a body mass index (BMI) of 25kg/ bb m*2 or more and less than 30kg/m*2
4) Those who can follow the diet and exercise guidelines during the intervention period

1) Those who have taken or are likely to take medications that affect body weight, blood sugar, lipids, or intestinal health within one month of the first visit
2) Those who have taken antibiotics within 2 months of the first visit or are likely to take it during the study
3) If you have,
    1.Uncontrolled hypertension 
   2. Those who have been diagnosed with diabetes or are determined to need treatment, or who have fasting blood sugar 
       level of 180 mg / dL or more
   3. Liver dysfunction or hepatobiliary disease
   4. Renal dysfunction 
   5. Hyperthyroidism and hypofunction, Cushing's syndrome
   6.  If you have a medical history of severe central nervous system disorders that require hospitalization or medication
   7. Those with severe cerebrovascular disease, heart disease. However, dizziness
       If there is no medical history, it may be excluded at the discretion of the researcher.
   8. Malignant tumor, lung disease, musculoskeletal disease, immune system or inflammatory disease
   9. A person who complains of gastrointestinal disorders or severe gastrointestinal symptoms such as heartburn, 
       indigestion or severe constipation
10) Those who have continuously consumed dietary supplements or herbal medicines affecting their weight, blood sugar, and lipids within one month of their first visit.
11) Those who have consistently consumed foods,Probiotics
12) Those who have hypersensitivity to the test / control food or ingredients or have experienced severe food allergic 
      reactions.
13) Participants in other human application research within 1 month of first visit
14) Pregnant or lactating women
15) Those who have difficulty using a smartphone or computer
16) If the researcher deems inappropriate to participate in this study

Body fat improvement indicator

Week 0(visit2), week 12(visit4)

Body fat related metabolic indicators

Week 0(visit2), week 12(visit4)